hydroxylamine has been researched along with bb3497 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ayscough, AP; Beckett, RP; Bragg, RA; Clements, JM; Davies, SJ; Doel, S; Grew, C; Launchbury, SB; Perkins, GM; Pratt, LM; Smith, HK; Spavold, ZM; Thomas, SW; Todd, RS; Whittaker, M | 1 |
Kanwar, AJ; Khuller, GK; Sharma, A; Sharma, S | 1 |
2 other study(ies) available for hydroxylamine and bb3497
Article | Year |
---|---|
Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the methylene spacer and the P1' side chain.
Topics: Amidohydrolases; Anti-Bacterial Agents; Enzyme Inhibitors; Hydrocarbons; Hydroxamic Acids; Hydroxylamine; Inhibitory Concentration 50; Metals; Methane; Microbial Sensitivity Tests; Molecular Mimicry; Oligopeptides; Structure-Activity Relationship | 2003 |
In vitro and ex vivo activity of peptide deformylase inhibitors against Mycobacterium tuberculosis H37Rv.
Topics: Amidohydrolases; Animals; Antibiotics, Antitubercular; Dipeptides; Drug Synergism; Drug Therapy, Combination; Hydroxamic Acids; Hydroxylamine; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Phenanthrolines; Protease Inhibitors; Rifampin; Tuberculosis | 2009 |